Test ID VITAE Vitamin A and Vitamin E, Serum
Shipping Instructions
Ship specimen in amber vial to protect from light.
Specimen Required
Patient Preparation:
1. Fasting: 12 hours, required; infants should have specimen collected before next feeding.
2. Patient must not consume any alcohol for 24 hours before specimen collection.
Supplies: Amber Frosted Tube, 5 mL (T915)
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Amber vial
Specimen Volume: 1 mL serum
Collection Instructions: Within 2 hours of collection, centrifuge and aliquot serum into a light protected plastic vial.
Useful For
Assessment of vitamin A and vitamin E status
Monitoring vitamin A and vitamin E therapy
Evaluating individuals with intestinal malabsorption of lipids
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| VITAP | Vitamin A, S | Yes, (Order VITA) | Yes |
| VITE | Vitamin E, S | Yes | Yes |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Vitamin A and Vitamin E, SSpecimen Type
SerumSpecimen Minimum Volume
Serum: 0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Refrigerated (preferred) | 28 days | LIGHT PROTECTED |
| Frozen | 28 days | LIGHT PROTECTED | |
| Ambient | 7 days | LIGHT PROTECTED |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
| Gross icterus | OK |
Clinical Information
Vitamin A:
The level of vitamin A in the plasma or serum is a reflection of the quantities of vitamin A and carotene (provitamin A) ingested and absorbed by the intestine (carotene is converted to vitamin A by intestinal absorptive cells and hepatocytes).
Vitamin A plays an essential role in the function of the retina (adaptation to dim light), is necessary for growth and differentiation of epithelial tissue, and is required for growth of bone, reproduction, and embryonic development. Together with certain carotenoids, vitamin A also plays a critical role in immune function, with deficiency associated with increased susceptibility and severity of some infectious diseases.
Degenerative changes in eyes and skin are commonly observed in vitamin A deficiency. In developing countries, vitamin A deficiency is the principal preventable cause of blindness. Poor adaptation of vision to darkness (nyctalopia, night blindness) is an early symptom that may be followed by degenerative changes in the retina. Severe or prolonged deficiency leads to xerophthalmia, which can result in dry eye, corneal ulcers, Bitot spots, keratomalacia, and ultimately blindness. Skin changes such as dry skin, generalized xerosis, and phrynoderma are commonly observed in conjunction with vision disorders caused by vitamin A deficiency.
Vitamin A in excess can be toxic. In particular, chronic vitamin A intoxication is a concern in normal adults who ingest more than 15 mg per day and children who ingest more than 6 mg per day of vitamin A over a period of several months. Manifestations are various and include dry skin, cheilosis, glossitis, vomiting, alopecia, bone demineralization and pain, hypercalcemia, lymph node enlargement, hyperlipidemia, amenorrhea, and features of pseudotumor cerebri with increased intracranial pressure and papilledema. Liver fibrosis with portal hypertension may also result. Congenital malformations, like spontaneous abortions, craniofacial abnormalities, and valvular heart disease have been described in pregnant women taking vitamin A in excess. Consequently, in pregnancy, the daily dose of vitamin A should not exceed 3 mg.
Vitamin E (alpha-tocopherol):
Vitamin E is the generic term for two different groups of methylated phenol compounds with a chromane alcoholic core linked to poly-carbon chains (tocopherols and tocotrienols).
These vitamins are all free radical scavengers, with a-Tocopherol being the most potent one in humans, as most of the related compounds are not re-secreted by the liver, thus leading to much lower circulating concentrations.
Vitamin E deficiency is very rare and mostly seen in patients with extreme malabsorption of fat and in patients with abetalipoproteinemia, a rare inborn error of metabolism. Patients with these conditions may develop hemolytic anemia, peripheral neuropathy, myopathy, retinopathy, and immune deficiency.
There is a large body of scientific studies that indicates positive effects on outcomes of various diseases if regular Vitamin E supplementation is provided; however, several trials have shown evidence of increasing bleeding risks at high Vitamin E doses. Therefore, tables of tolerable doses in children and adults have been established, which should not be exceeded.
Deficiencies of vitamins A and E may arise from poor nutrition or from intestinal malabsorption. Individuals at risk, especially children, include those with bowel disease, pancreatic disease, chronic cholestasis, celiac disease, cystic fibrosis, and intestinal lymphangiectasia. Infantile cholangiopathies that may lead to malabsorption of vitamins A and E include intrahepatic dysplasia and rubella-related embryopathy.
Reference Values
VITAMIN A (RETINOL)
0-6 years: 11.3-64.7 mcg/dL
7-12 years: 12.8-81.2 mcg/dL
13-17 years: 14.4-97.7 mcg/dL
≥18 years: 32.5-78.0 mcg/dL
VITAMIN E (ALPHA-TOCOPHEROL)
0-17 years: 3.8-18.4 mg/L
≥18 years: 5.5-17.0 mg/L
Interpretation
Vitamin A:
The World Health Organization recommends supplementation when vitamin A levels fall below 20.0 mcg/dL. Severe deficiency is indicated at levels less than 10.0 mcg/dL. There is no widely accepted serum vitamin A level associated with toxicity.
Vitamin E (alpha-tocopherol):
Vitamin E levels below the reference interval suggest deficiency
Conversely, Vitamin E concentrations significantly above the upper healthy reference population range might indicate that Vitamin E intake exceeds the tolerable upper daily intake level(s).
The rare occurrence of low Vitamin A and E levels might correlate with potential deficiency and investigation of potential fat malabsorptions should be considered.
Cautions
Acute alcohol ingestion may result in increased serum vitamin A levels. Patients should abstain from alcohol for 24 hours prior to collection.
Testing of nonfasting specimens or the use of vitamin supplementation can result in elevated serum vitamin concentrations. Reference values were established in patients who were fasting.
Clinical Reference
1. Sodi R, Taylor A. Vitamins and trace elements In: Rifai N, Horvath AR, Wittwer CT, eds. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. 8th ed. Elsevier; 2019:466-487
2. National Institute of Mental Health. Vitamin A and Carotenoids-Fact Sheet for Health Professionals. U.S. Department of Health and Human Services, National Institutes of Health. 2023.
3. Greaves RF, Woollard GA, Hoad KE, Walmsley TA, Johnson LA, Briscoe S, Koetsier S, Harrower T, Gill JP. Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood. Clin Biochem Rev. 2014;35(2):81-113
4. Tanumihardjo SA, Russell RM, Stephensen CB, Gannon BM, Craft NE, Haskell MJ, Lietz G, Schulze K, Raiten DJ. Biomarkers of Nutrition for Development (BOND)-Vitamin A Review. J Nutr. 2016;146(9):1816S-48S. doi:10.3945/jn.115.229708
5. Wiseman EM, Bar-El Dadon S, Reifen R. The vicious cycle of vitamin a deficiency: A review. Crit Rev Food Sci Nutr. 2017;57(17):3703-3714. doi:10.1080/10408398.2016.1160362
6. Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191-201. doi:10.1093/ajcn/83.2.191
7. Mehta S, Fawzi W. Effects of vitamins, including vitamin A, on HIV/AIDS patients. Vitam Horm. 2007;75:355-83. doi:10.1016/S0083-6729(06)75013-0
8. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351(1):23-32. doi:10.1056/NEJMoa040541
9. Wong CY, Chu DH. Cutaneous signs of nutritional disorders. Int J Womens Dermatol. 2021;7(5Part A):647-652. doi:10.1016/j.ijwd.2021.09.003
10. National Institute of Mental Health. Vitamin E-Fact Sheet for Health Professionals. U.S. Department of Health and Human Services, National Institutes of Health. 2023.
11. Greaves RF, Woollard GA, Hoad KE, Walmsley TA, Johnson LA, Briscoe S, Koetsier S, Harrower T, Gill JP. Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood. Clin Biochem Rev. 2014;35(2):81-113
12. Brigelius-Flohé R, Traber MG. Vitamin E: function and metabolism. FASEB J. 1999;13(10):1145-55
13. Traber MG, Head B. Vitamin E: How much is enough, too much and why! Free Radic Biol Med. 2021;177:212-225. doi:10.1016/j.freeradbiomed.2021.10.028
14. Traber MG. Vitamin E inadequacy in humans: causes and consequences. Adv Nutr. 2014;5(5):503-14. doi:10.3945/an.114.006254
Day(s) Performed
Monday through Friday, Sunday
Report Available
2 to 5 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
84446
84590
NY State Approved
YesMethod Description
Deuterated vitamin A (d6-all-trans retinol) and vitamin E (d6-alpha-tocopherol) are added to serum as an internal standards. Vitamin A (all-trans retinol), vitamin E (alpha-tocopherol), and the deuterated internal standards are extracted from the specimens and analyzed by liquid chromatography tandem mass spectrometry.(Unpublished Mayo method)